Skip to content

Clinical trials

Active, not recruiting Diabetes Mellitus, Type 2 trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Active, not recruiting Country / region: Canada Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20151
20181
20192
20211
20225
20236
20245
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of British Columbia4
Eli Lilly and Company3
University of Manitoba3
GT Metabolic Solutions, Inc.2
Novo Nordisk A/S2
Alnylam Pharmaceuticals1
Amgen1
Applied Therapeutics, Inc.1
AstraZeneca1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 227
Obesity9
Overweight4
Diabetes Mellitus3
Endocrine System Diseases3
Glucose Metabolism Disorders3
Metabolic Diseases3
Cardiovascular Diseases2
Diabetes, Gestational2
Hypertension2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.